List of insiders holdings for Actinium Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Button Diane S President/Secretary/Treasurer | 2007-02-07 12:45:30 | 20,000,000 0 | 20,000,000 | Form 13D |
| 2 | SETH SANDESH Chief Executive Officer | 2026-09-04 17:00:26 | 3,095,755 0 | 3,095,755 | Form 4 |
| 3 | Memorial Sloan-Kettering Cancer Center AHLB Holdings LLC Actinium Holdings Ltd. 10% Owner | 2018-02-12 21:24:25 | 1,230,954 0 | 1,230,954 | Form 13G |
| 4 | Memorial Sloan-Kettering Cancer Center 10% Owner | 2018-02-12 21:24:25 | 1,230,954 0 | 1,230,954 | Form 13G |
| 5 | Talley John V. CEO and President | 2013-01-03 14:37:41 | 699,300 0 | 699,300 | Form 3 |
| 6 | David Matthew T Chief Financial Officer | 2026-10-16 17:11:10 | 500,000 0 | 500,000 | Form 4 |
| 7 | Heeger Steffen Wilhem Chief Medical Officer | 2026-09-10 17:00:02 | 403,868 0 | 403,868 | Form 3 |
| 8 | Kapur Anil Chief Commercial Officer | 2019-07-16 16:59:10 | 400,000 0 | 400,000 | Form 4 |
| 9 | Kamal Adeela Chief Scientific Officer | 2026-09-10 17:00:03 | 333,648 0 | 333,648 | Form 3 |
| 10 | DAVE KAUSHIK J CEO and Interim CFO | 2017-03-16 18:18:18 | 250,000 0 | 250,000 | Form 4 |
| 11 | Nicholson C. David Director | 2026-09-04 17:00:30 | 157,500 0 | 157,500 | Form 4 |
| 12 | Steinhart Richard I Director | 2026-09-04 17:00:25 | 157,316 0 | 157,316 | Form 4 |
| 13 | Shetty Ajit Director | 2026-09-04 17:00:31 | 154,757 0 | 154,757 | Form 4 |
| 14 | Chell Jeffrey W. Director | 2026-09-04 17:00:23 | 154,000 0 | 154,000 | Form 4 |
| 15 | Ray Nitya G. Executive VP | 2018-07-17 17:17:59 | 75,000 0 | 75,000 | Form 4 |
| 16 | TRAVERSA SERGIO Director | 2017-03-16 16:35:30 | 75,000 0 | 75,000 | Form 4 |
| 17 | CICIC DRAGAN Chief Technology Officer | 2017-03-16 16:07:49 | 75,000 0 | 75,000 | Form 4 |
| 18 | Berger Mark Stanley Chief Medical Officer | 2021-09-03 17:04:11 | 67,164 0 | 67,164 | Form 4 |
| 19 | Ludwig Dale L. Chief Science & Tech. Officer | 2020-08-14 17:03:13 | 50,000 0 | 50,000 | Form 4 |
| 20 | Almenoff June Sherie Director | 2026-09-04 17:00:28 | 45,000 0 | 45,000 | Form 4 |
| 21 | GUAGENTI ENZA Chief Financial Officer | 2013-01-02 18:46:09 | 33,300 0 | 33,300 | Form 3 |
| 22 | MAZANET ROSEMARY Director | 2013-05-22 20:04:23 | 100 0 | 100 | Form 4 |
| 23 | O'Loughlin Steve Chief Financial Officer | 2025-04-02 18:20:36 | 0 0 | 0 | Form 4 |